SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-020283
Filing Date
2020-07-23
Accepted
2020-07-23 21:20:37
Documents
2
Period of Report
2020-07-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6046
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4599
  Complete submission text file 0000899243-20-020283.txt   12116
Mailing Address PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080
Business Address
Bolte Axel (Reporting) CIK: 0001579247 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39397 | Film No.: 201044887

Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Issuer) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations